185 related articles for article (PubMed ID: 34372984)
21. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
Nielsen JS; Gyrd-Hansen D; Kjaer T
Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
[TBL] [Abstract][Full Text] [Related]
22. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
Kouakou CRC; He J; Poder TG
Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
[TBL] [Abstract][Full Text] [Related]
23. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
[TBL] [Abstract][Full Text] [Related]
24. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
[TBL] [Abstract][Full Text] [Related]
25. Willingness to pay for one quality-adjusted life year in Iran.
Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
[TBL] [Abstract][Full Text] [Related]
26. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.
Lin PJ; Cangelosi MJ; Lee DW; Neumann PJ
Value Health; 2013; 16(5):797-805. PubMed ID: 23947973
[TBL] [Abstract][Full Text] [Related]
27. Willingness-to-pay for cancer treatment and outcome: a systematic review.
Yong ASJ; Lim YH; Cheong MWL; Hamzah E; Teoh SL
Eur J Health Econ; 2022 Aug; 23(6):1037-1057. PubMed ID: 34853930
[TBL] [Abstract][Full Text] [Related]
28. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
29. Decision-makers' preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity.
Linley WG; Hughes DA
Pharmacoeconomics; 2013 Apr; 31(4):345-55. PubMed ID: 23516033
[TBL] [Abstract][Full Text] [Related]
30. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
[TBL] [Abstract][Full Text] [Related]
31. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
32. The value of dementia care towards the end of life-A contingent valuation study.
Bhattarai N; Mason H; Kernohan A; Poole M; Bamford C; Robinson L; Vale L
Int J Geriatr Psychiatry; 2020 May; 35(5):489-497. PubMed ID: 31912572
[TBL] [Abstract][Full Text] [Related]
33. Willingness to pay for the maintenance of equity in a local ivermectin distribution scheme in Toro, Northern Nigeria.
Onwujekwe OE; Shu EN; Okonkwo PO
Public Health; 1999 Jul; 113(4):193-4. PubMed ID: 10483083
[TBL] [Abstract][Full Text] [Related]
34. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
35. Monetary value of health-a practical decision-making framework combining equity considerations and WTP.
Ribarić E; Velić I; Bobinac A
Eur J Health Econ; 2024 May; ():. PubMed ID: 38769211
[TBL] [Abstract][Full Text] [Related]
36. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
[TBL] [Abstract][Full Text] [Related]
37. Defining monetary values for quality of life improvements: an exploratory study.
Lachaine J; Laurier C; Contandriopoulos AP
Pharmacoeconomics; 2003; 21(12):865-74. PubMed ID: 12908842
[TBL] [Abstract][Full Text] [Related]
38. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
39. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
Neumann PJ; Johannesson M
Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]